Abramson, J. 2004. Overdosed America: The Broken Promise of American Medicine (Harper Collins: New York).Google Scholar

Abramson, J. H., and Abramson, Z. H.. 2001. Making Sense of Data: A Self-Instruction Manual on the Interpretation of Epidemiological Data (Oxford University Press: New York).CrossRefGoogle Scholar

Altshuler, L., Suppes, T., Black, D., et al. 2003. “Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up,” Am J Psychiatry, 160: 1252–62.CrossRefGoogle ScholarPubMed

Andrews, G., Anstey, K., Brodaty, H., Issakidis, C., and Luscombe, G.. 1999. “Recall of depressive episode 25 years previously,” Psychol Med, 29: 787–91.CrossRefGoogle ScholarPubMed

Andrews, P. W., Kornstein, S. G., Halberstadt, L. J., Gardner, C. O., and Neale, M. C.. 2011. “Blue again: Perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression,” Front Psychol, 2: 1–24.CrossRefGoogle ScholarPubMed

Angell, M. 2005. The Truth about the Drug Companies (Random House: New York).Google Scholar

Bachmann, S. 2018. “Epidemiology of suicide and the psychiatric perspective,” Int J Environ Res Public Health, 15: 1425.CrossRefGoogle ScholarPubMed

Barbui, C., Cipriani, A., Malvini, L., and Tansella, M.. 2006. “Validity of the impact factor of journals as a measure of randomized controlled trial quality,” J Clin Psychiatry, 67: 37–40.CrossRefGoogle ScholarPubMed

Barnard, G. A. , and Bayes, T.. 1958. “Studies in the history of probability and statistics: IX. Thomas Bayes’s essay Towards Solving a Problem in the Doctrine of Chances,” Biometrika, 45: 293–315. https://doi.org/10.2307/2333180.CrossRefGoogle Scholar

Basoglu, M., Marks, I., Livanou, M., and Swinson, R.. 1997. “Double-blindness procedures, rater blindness, and ratings of outcome: Observations from a controlled trial,” Arch Gen Psychiatry, 54: 744–8.CrossRefGoogle ScholarPubMed

Baxt, W. G., Waeckerle, J. F., Berlin, J. A., and Callaham, M. L.. 1998. “Who reviews the reviewers? Feasibility of using a fictitious manuscript to evaluate peer reviewer performance,” Ann Emerg Med, 32: 310–7.CrossRefGoogle ScholarPubMed

Beck, A. T. 2019. “A 60-year evolution of cognitive theory and therapy,” Perspect Psychol Sci, 14: 16–20.CrossRefGoogle ScholarPubMed

Benson, K., and Hartz, A. J.. 2000. “A comparison of observational studies and randomized, controlled trials,” N Engl J Med, 342: 1878–86.CrossRefGoogle ScholarPubMed

Berry, D. A. 1993. “A case for Bayesianism in clinical trials,” Stat Med, 12: 1377–93.CrossRefGoogle ScholarPubMed

Blackwelder, W. C. 1982. “‘Proving the null hypothesis’ in clinical trials,” Control Clin Trials, 3: 345–53.CrossRefGoogle ScholarPubMed

Blair-West, G. W., Cantor, C. H., Mellsop, G. W., and Eyeson-Annan, M. L.. 1999. “Lifetime suicide risk in major depression: Sex and age determinants,” J Affect Disord, 55: 171–8.CrossRefGoogle ScholarPubMed

Blank, A. 2006. “A piece of my mind: Swan’s way,” JAMA, 296: 1041–2.CrossRefGoogle ScholarPubMed

Bolwig, T. G. 2006. “Psychiatry and the humanities,” Acta Psychiatr Scand, 114: 381–3.CrossRefGoogle ScholarPubMed

Borges, S., Chen, Y. F., Laughren, T. P., et al. 2014. “Review of maintenance trials for major depressive disorder: A 25-year perspective from the US Food and Drug Administration,” J Clin Psychiatry, 75: 205–14.CrossRefGoogle ScholarPubMed

Bowden, C. L., Calabrese, J. R., Sachs, G. S., et al. 2003. “A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder,” Arch Gen Psychiatry, 60: 392–400.CrossRefGoogle ScholarPubMed

Bowden, C. L., Swann, A. C., Calabrese, J. R., et al. 1997. “Maintenance clinical trials in bipolar disorder: Design implications of the divalproex-lithium-placebo study,” Psychopharmacol Bull, 33: 693–9.Google ScholarPubMed

Brazill, K. P., Warnick, S., Jr., and White, C.. 2018. “Revisiting the canons of psychiatry: Teaching the fundamentals of CATIE, STAR*D, and STEP-BD to family medicine residents,” Int J Psychiatry Med, 53: 455–63.CrossRefGoogle ScholarPubMed

Brown, H. 2007. “How impact factors changed medical publishing – and science,” BMJ, 334: 561–4.CrossRefGoogle ScholarPubMed

Calabrese, J. R., Bowden, C. L., Sachs, G. S., et al. 1999. “A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression: Lamictal 602 Study Group,” J Clin Psychiatry, 60: 79–88.CrossRefGoogle ScholarPubMed

Calabrese, J. R., Bowden, C. L., Sachs, G., et al. 2003. “A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder,” J Clin Psychiatry, 64: 1013–24.CrossRefGoogle ScholarPubMed

Calabrese, J. R., Huffman, R. F., White, R. L., et al. 2008. “Lamotrigine in the acute treatment of bipolar depression: Results of five double-blind, placebo-controlled clinical trials,” Bipolar Disord, 10: 323–33.CrossRefGoogle ScholarPubMed

Calabrese, J. R., Keck, P. E., Jr., Macfadden, W., et al. 2005. “A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression,” Am J Psychiatry, 162: 1351–60.CrossRefGoogle ScholarPubMed

Calabrese, J. R., Suppes, T., Bowden, C. L., et al. 2000. “A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder: Lamictal 614 Study Group,” J Clin Psychiatry, 61: 841–50.CrossRefGoogle ScholarPubMed

Capra, W. B. 2004. “Comparing the power of the discontinuation design to that of the classic randomized design on time-to-event endpoints,” Control Clin Trials, 25: 168–77.CrossRefGoogle ScholarPubMed

Carroll, B. J. 2004. “Adolescents with depression,” JAMA, 292: 2577–9.Google ScholarPubMed

Carroll, B. J. 2006. “Ten rules of academic life: Reflections on the career of an affective disorders researcher,” J Affect Disord, 92: 7–12.CrossRefGoogle ScholarPubMed

Cipriani, A., Furukawa, T. A., Salanti, G., et al. 2009. “Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis,” Lancet, 373: 746–58.CrossRefGoogle ScholarPubMed

Cipriani, A., Furukawa, T. A., Salanti, G., et al. 2018. “Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis,” Lancet, 391: 1357–66.CrossRefGoogle ScholarPubMed

Cohen, J. 1994. “The earth is round (p < 0.05),” Am Psychol, 49: 997–1003.CrossRefGoogle Scholar

Conner, A., Azrael, D., and Miller, M.. 2019. “Suicide case-fatality rates in the United States, 2007 to 2014: A nationwide population-based study,” Ann Intern Med, 171: 885–95.CrossRefGoogle ScholarPubMed

Das, A. K., Olfson, M., Gameroff, M. J., et al. 2005. “Screening for bipolar disorder in a primary care practice,” JAMA, 293: 956–63.CrossRefGoogle Scholar

Dawson, B., and Trapp, R. G.. 2001. Basic and Clinical Biostatistics (McGraw-Hill: New York).Google Scholar

Dennett, D. D. 2000. “Postmodernism and truth,” in Hintikka, J., Neville, S., Sosa, E., and Olsen, A. (eds.), Proceedings of the 20th World Congress of Philosophy, Volume 8 (Philosophy Documentation Center: Charlottesville, VA), pp. 93–100.CrossRefGoogle Scholar

Deshauer, D., Fergusson, D., Duffy, A., Albuquerque, J., and Grof, P.. 2005. “Re-evaluation of randomized control trials of lithium monotherapy: A cohort effect,” Bipolar Disord, 7: 382–7.CrossRefGoogle ScholarPubMed

DeVito, N. J., and Goldacre, B.. 2021. “Evaluation of compliance with legal requirements under the FDA Amendments Act of 2007 for timely registration of clinical trials, data verification, delayed reporting, and trial document submission,” JAMA Intern Med, 181: 1128–30.CrossRefGoogle ScholarPubMed

Doll, R. 2002. “Proof of causality: Deduction from epidemiological observation,” Perspect Biol Med, 45: 499–515.CrossRefGoogle ScholarPubMed

El-Mallakh, R. and Briscoe, B.. 2012 “Studies of long-term use of antidepressants: How should the data from them be interpreted?” CNS Drugs, 26: 97–109. https://doi.org/10.2165/11599450-000000000-00000.CrossRefGoogle ScholarPubMed

Emanuel, E. J., and Miller, F. G.. 2001. “The ethics of placebo-controlled trials: A middle ground,” N Engl J Med, 345: 915–9.CrossRefGoogle ScholarPubMed

Eysenck, H. J. 1994. “Meta-analysis and its problems,” BMJ, 309: 789–92.CrossRefGoogle ScholarPubMed

Fava, M., Evins, A. E., Dorer, D. J., and Schoenfeld, D. A.. 2003. “The problem of the placebo response in clinical trials for psychiatric disorders: Culprits, possible remedies, and a novel study design approach,” Psychother Psychosom, 72: 115–27.CrossRefGoogle Scholar

FDA (Food and Drug Administration). 2019. “Guidance for Industry: Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products.”Docket number FDA-2012-D-1145. Issued by Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Accessible at www.fda.gov/regulatory-information/search-fda-guidance-documents/enrichment-strategies-clinical-trials-support-approval-human-drugs-and-biological-products.Google Scholar

Feinstein, A. R. 1977. Clinical Biostatistics (Mosby: St. Louis).CrossRefGoogle ScholarPubMed

Feinstein, A. R. 1995. “Meta-analysis: Statistical alchemy for the 21st century,” J Clin Epidemiol, 48: 71–9.CrossRefGoogle Scholar

Feinstein, A. R. and Horwitz, R. I.. 1997. “Problems in the ‘evidence’ of ‘evidence-based medicine,’” Am. J. Med., 103: 529–35. https://doi.org/10.1016/s0002-9343(97)00244-1.CrossRefGoogle ScholarPubMed

Fink, M., and Taylor, M. A.. 2007. “Electroconvulsive therapy: Evidence and challenges,” JAMA, 298: 330–2.CrossRefGoogle ScholarPubMed

Fink, M., and Taylor, M. A. 2008. “The medical evidence-based model for psychiatric syndromes: Return to a classical paradigm,” Acta Psychiatr Scand, 117: 81–4.CrossRefGoogle ScholarPubMed

Fisher, B., Costantino, J., Redmond, C., et al. 1989. “A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors,” N Engl J Med, 320: 479–84.Google ScholarPubMed

Fisher, RA. 1947. The Design of Experiments (Oliver and Boyd: London).Google Scholar

Fisher, RA. 1971 [1935]. The Design of Experiments, 9th edition (Macmillan: New York).Google Scholar

Fletcher, W. 1907. “Rice and beri-beri: Preliminary report on an experiment conducted at the Kuala Lampur Lunatic Asylum,” Lancet, i: 1776–79.Google Scholar

Fluckiger, C., Del Re, A. C., Wampold, B. E., and Horvath, A. O.. 2018. “The alliance in adult psychotherapy: A meta-analytic synthesis,” Psychotherapy (Chic), 55: 316–40.CrossRefGoogle Scholar

Fluckiger, C., Del Re, A. C., Wampold, B. E., Symonds, D., and Horvath, A. O.. 2012. “How central is the alliance in psychotherapy? A multilevel longitudinal meta-analysis,” J Couns Psychol, 59: 10–17.CrossRefGoogle Scholar

Foucault, M. 1994. The Birth of the Clinic (Vintage: New York).Google Scholar

Freidlin, B., and Simon, R.. 2005. “Evaluation of randomized discontinuation design,” J Clin Oncol, 23: 5094–8.CrossRefGoogle ScholarPubMed

Friedman, L. M., Furberg, C. D., and DeMets, D. L.. 1998a. Fundamentals of Clinical Trials (Springer-Verlag: New York).CrossRefGoogle Scholar

Friedman, L. M., Furberg, C. D., and DeMets, D. L.. 1998b. Fundamentals of Clinical Trials, 3rd edition (Springer: New York).CrossRefGoogle Scholar

Geddes, J. R., Carney, S. M., Davies, C., et al. 2003. “Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review,” Lancet, 361: 653–61.CrossRefGoogle ScholarPubMed

Geddes, J. R., Goodwin, G. M., Rendell, J., et al. 2010. “Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial,” Lancet, 375: 385–95.Google ScholarPubMed

Gehlbach, S. 2006. Interpreting the Medical Literature (McGraw-Hill: New York).Google Scholar

Ghaemi, S. N. 2003. The Concepts of Psychiatry: A Pluralistic Approach to the Mind and Mental Illness (Johns Hopkins University Press: Baltimore, MD).Google Scholar

Ghaemi, S. N. 2008. “Toward a Hippocratic psychopharmacology,” Can J Psychiatry, 53: 189–96.CrossRefGoogle Scholar

Ghaemi, S. N. 2009. “The failure to know what isn’t known: Negative publication bias with lamotrigine and a glimpse inside peer review,” Evid Based Ment Health, 12: 65–8.CrossRefGoogle Scholar

Ghaemi, S. N., Gilmer, W. S., Goldberg, J. F., et al. 2007. “Divalproex in the treatment of acute bipolar depression: A preliminary double-blind, randomized, placebo-controlled pilot study,” J Clin Psychiatry, 68: 1840–4.CrossRefGoogle ScholarPubMed

Ghaemi, S. N., Shirzadi, A. A., and Filkowski, M. M.. 2008a. “Publication bias and the pharmaceutical industry: The case of lamotrigine in bipolar disorder,” Medscape J Med, 9: 211.Google Scholar

Ghaemi, S. N., Soldani, F., and Hsu, D. J.. 2003. “Evidence-based pharmacotherapy of bipolar disorder.” Int. J. Neuropsychopharmacol, 6: 303–8. https://doi.org/10.1017/S1461145703003626.Google ScholarPubMed

Ghaemi, S. N., Wingo, A. P., Filkowski, M. A., and Baldessarini, R. J.. 2008b. “Long-term antidepressant treatment in bipolar disorder: Meta-analyses of benefits and risks,” Acta Psychiatr Scand, 118: 374–56.CrossRefGoogle ScholarPubMed

Goff, D. C., Falkai, P., Fleischhacker, W. W., et al. 2017. “The long-term effects of antipsychotic medication on clinical course in schizophrenia,” Am J Psychiatry, 174: 840–49.CrossRefGoogle ScholarPubMed

Goldberg, J. F., and Whiteside, J. E.. 2002. “The association between substance abuse and antidepressant-induced mania in bipolar disorder: A preliminary study,” J Clin Psychiatry, 63: 791–5.CrossRefGoogle ScholarPubMed

Goodman, S. N. 1999. “Toward evidence-based medical statistics. 2: The Bayes factor,” Ann Intern Med, 130: 1005–13.Google ScholarPubMed

Goodwin, F. K., and Jamison, K. R.. 2007. Manic Depressive Illness, 2nd edition (Oxford University Press: New York).Google Scholar

Goodwin, F. K., Whitham, E. A., and Ghaemi, S. N.. 2011. “Maintenance treatment study designs in bipolar disorder: Do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers?,” CNS Drugs, 25: 819–27.Google ScholarPubMed

Hammad, T. A., Laughren, T., and Racoosin, J.. 2006. “Suicidality in pediatric patients treated with antidepressant drugs,” Arch Gen Psychiatry, 63: 332–9.CrossRefGoogle ScholarPubMed

Healy, D. 2001. The Creation of Psychopharmacology (Harvard University Press: Cambridge, MA).Google Scholar

Hill, A. B. 1962. Statistical Methods in Clinical and Preventive Medicine (Oxford University Press: New York).Google Scholar

Hill, A. B. 1965. “The environment and disease: Association or causation?,” Proc R Soc Med, 58: 295–300.Google ScholarPubMed

Hill, A. B. 1971. Principles of Medical Statistics (Oxford University Pres: New York).Google Scholar

Hill, A. B. 1962b. Statistical Methods in Clinical and Preventive Medicine (Oxford University Press: New York).Google Scholar

Horton, R. 2002. “The hidden research paper,” JAMA, 287: 2775–8.CrossRefGoogle ScholarPubMed

Hrobjartsson, A., and Gotzsche, P. C.. 2001. “Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment,” N Engl J Med, 344: 1594–602.CrossRefGoogle ScholarPubMed

Hummer, M., Holzmeister, R., Kemmler, G., et al. 2003. “Attitudes of patients with schizophrenia toward placebo-controlled clinical trials,” J Clin Psychiatry, 64: 277–81.CrossRefGoogle ScholarPubMed

Hunt, M. 1997. How Science Takes Stock: The Story of Meta-Analysis (Russell Sage Foundation: London).Google Scholar

IMS. 2011. “The use of medicines in the United States: Review of 2010.” IMS Institute for Healthcare Informatics: Parsippany, NJ.Google Scholar

Ioannidis, J. P. 2005. “Contradicted and initially stronger effects in highly cited clinical research,” JAMA, 294: 218–28.CrossRefGoogle ScholarPubMed

Isacsson, G., and Rich, C. L.. 2014. “Antidepressant drugs and the risk of suicide in children and adolescents,” Paediatr Drugs, 16: 115–22.CrossRefGoogle ScholarPubMed

Jaeschke, R., Guyatt, G., and Sackett, D. L.. 1994. “Users’ guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group,” JAMA, 271: 389–91.Google Scholar

James, W. 1956 (1897). “Is life worth living?’ in, The Will to Believe and Other Essays in Popular Philosophy (Dover: New York).Google Scholar

Jaspers, K. 1997 [1959]. General Psychopathology: Volumes 1 and 2 (Johns Hopkins University Press: Baltimore, MD).Google Scholar

Jefferson, T., Alderson, P., Wager, E., and Davidoff, F.. 2002. “Effects of editorial peer review: A systematic review,” JAMA, 287: 2784–6.CrossRefGoogle ScholarPubMed

Joffe, R. T., MacQueen, G. M., Marriott, M., and Young, L. T.. 2005. “One-year outcome with antidepressant-treatment of bipolar depression,” Acta Psychiatr Scand, 112: 105–9.CrossRefGoogle ScholarPubMed

Jureidini, J. N., Doecke, C. J., Mansfield, P. R., et al. 2004. “Efficacy and safety of antidepressants for children and adolescents,” BMJ, 328: 879–83.CrossRefGoogle ScholarPubMed

Karrison, T. G., Ratain, M. J., Stadler, W. M., and Rosner, G. L.. 2012. “Estimation of progression-free survival for all treated patients in the randomized discontinuation trial design,” Am Stat, 66: 155–62.CrossRefGoogle ScholarPubMed

Katz, I. R., Rogers, M. P., Lew, R., et al. 2022. “Lithium treatment in the prevention of repeat suicide-related outcomes in veterans with major depression or bipolar disorder: A randomized clinical trial,” JAMA Psychiatry, 79: 24–32.CrossRefGoogle ScholarPubMed

Kellner, C. H., Knapp, R. G., Petrides, G., et al. 2006. “Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: A multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE),” Arch Gen Psychiatry, 63: 1337–44.CrossRefGoogle Scholar

Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., et al. 2008. “Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration,” PLoS Med, 5: e45.CrossRefGoogle ScholarPubMed

Kopec, J. A., Abrahamowicz, M., and Esdaile, J. M.. 1993. “Randomized discontinuation trials: Utility and efficiency,” J Clin Epidemiol, 46: 959–71.CrossRefGoogle ScholarPubMed

Kraemer, H. C. and Kupfer, D. J.. (2006) “Size of treatment effects and their importance to clinical research and practice,” Biol Psychiatry 59: 990–6.CrossRefGoogle ScholarPubMed

Krupnick, J. L., Sotsky, S. M., Simmens, S., et al. 1996. “The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program,” J Consult Clin Psychol, 64: 532–9.CrossRefGoogle ScholarPubMed

Kushner, S. F., Khan, A., Lane, R., and Olson, W. H.. 2006. “Topiramate monotherapy in the management of acute mania: Results of four double-blind placebo-controlled trials,” Bipolar Disord, 8: 15–27.CrossRefGoogle ScholarPubMed

Lang, J. M., Rothman, K. J., and Cann, C. I.. 1998. “That confounded P-value,” Epidemiology, 9: 7–8.Google ScholarPubMed

Leon, A. C. 2004. “Multiplicity-adjusted sample size requirements: A strategy to maintain statistical power with Bonferroni adjustments,” J Clin Psychiatry, 65: 1511–4.CrossRefGoogle ScholarPubMed

Leucht, S., Tardy, M., Komossa, K., et al. 2012. “Maintenance treatment with antipsychotic drugs for schizophrenia,” Cochrane Database Syst Rev, 5: CD008016.Google Scholar

Levine, R., and Fink, M.. 2006. “The case against evidence-based principles in psychiatry,” Med Hypotheses, 67: 401–10.CrossRefGoogle ScholarPubMed

Lexchin, J., Bero, L. A., Djulbegovic, B., and Clark, O.. 2003. “Pharmaceutical industry sponsorship and research outcome and quality: Systematic review,” BMJ, 326: 1167–70.CrossRefGoogle ScholarPubMed

Mack, JE. 1995. Abduction: Human Encounters with Aliens (Ballantine: New York).Google Scholar

Makkreel, R. 1992. Dilthey: Philosopher of the Human Studies (Princeton University Press: Princeton, NJ).Google Scholar

Mann, J. J. , Emslie, G., Baldessarini, R. J., et al. 2006. “ACNP Task Force report on SSRIs and suicidal behavior in youth,” Neuropsychopharmacol : Off Publ Am Coll Neuropsychopharmacol, 31: 473–92. https://doi.org/10.1038/sj.npp.1300958.CrossRefGoogle ScholarPubMed

Manwani, S. G., Pardo, T. B., Albanese, M. J., et al. 2006. “Substance use disorder and other predictors of antidepressant-induced mania: A retrospective chart review,” J Clin Psychiatry, 67: 1341–5.CrossRefGoogle ScholarPubMed

March, J., Silva, S., Petrycki, S., et al. 2004. “Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial,” JAMA, 292: 807–20.Google ScholarPubMed

Marcus, R. N., McQuade, R. D., Carson, W. H., et al. 2008. “The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A second multicenter, randomized, double-blind, placebo-controlled study,” J Clin Psychopharmacol, 28: 156–65.CrossRefGoogle ScholarPubMed

Martin, D. J., Garske, J. P., and Davis, M. K.. 2000. “Relation of the therapeutic alliance with outcome and other variables: A meta-analytic review,” J Consult Clin Psychol, 68: 438–50.CrossRefGoogle ScholarPubMed

McHugh, P. R. 1996. “Hippocrates a la mode,” Nat Med, 2: 507–9.CrossRefGoogle Scholar

Menand, L. 2001. The Metaphysical Club (Farrar, Strauss, and Giroux: New York).Google Scholar

Miettinen, O. S. and Cook, E. F.. 1981. “Confounding: Essence and detection,” Am J Epidemiol, 114: 593–603.CrossRefGoogle ScholarPubMed

Mills, C. W. 1963. Power, Politics, and People (Oxford University Press: New York).Google Scholar

Moncrieff, J., Wessely, S., and Hardy, R.. 1998. “Meta-analysis of trials comparing antidepressants with active placebos,” Br J Psychiatry, 172: 227–31.CrossRefGoogle ScholarPubMed

Moynihan, R. 2008. “Key opinion leaders: Independent experts or drug representatives in disguise?,” BMJ, 336: 1402–3.CrossRefGoogle ScholarPubMed

Moynihan, R., Heath, I., and Henry, D.. 2002. “Selling sickness: The pharmaceutical industry and disease mongering,” BMJ, 324: 886–91.CrossRefGoogle ScholarPubMed

Myers, M. G., Cairns, J. A., and Singer, J.. 1987. “The consent form as a possible cause of side effects,” Clin Pharmacol Ther, 42: 250–3.CrossRefGoogle ScholarPubMed

Olmsted, J. M. D. 1952. Claude Bernard and the Experimental Method in Medicine (H. Schuman: London).Google Scholar

Osler, W. 1948. Aequanimitas (The Blakiston Company: Philadelphia, PA).Google Scholar

Pande, A. C., Crockatt, J. G., Janney, C. A., Werth, J. L., and Tsaroucha, G.. 2000. “Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group,” Bipolar Disord, 2: 249–55.CrossRefGoogle ScholarPubMed

Parascandola, M. 2004. “Skepticism, statistical methods, and the cigarette: A historical analysis of a methodological debate,” Perspect Biol Med, 47: 244–61.CrossRefGoogle ScholarPubMed

Parker, G., Tully, L., Olley, A., and Hadzi-Pavlovic, D.. 2006. “SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study,” J Affect Disord, 92: 205–14.CrossRefGoogle ScholarPubMed

Patsopoulos, N. A., Ioannidis, J. P., and Analatos, A. A.. 2006. “Origin and funding of the most frequently cited papers in medicine: Database analysis,” BMJ, 332: 1061–4.CrossRefGoogle Scholar

Peirce, C. 1958a. “The fixation of belief,” in Weiner, P. (ed.), Selected Writings (Dover Publications: New York), pp. 91–112.Google Scholar

Peirce, C. 1958b. Selected Works (Dover: New York).Google Scholar

Phelps, J. R., and Ghaemi, S. N.. 2006. “Improving the diagnosis of bipolar disorder: Predictive value of screening tests,” J Affect Disord, 92: 141–8.CrossRefGoogle ScholarPubMed

Pickering, G. W. 1949. “The place of the experimental method in medicine,” Proc R Soc Med, 42: 229–34.Google ScholarPubMed

Poe, E. A. 1845. Graham’s Magazine.Google Scholar

Pollard, P. , and Richardson, J. T. 1987. “On the probability of making Type I errors,” Psychol. Bull, 102: 159–63.CrossRefGoogle Scholar

Popper, K. 1959. The Logic of Scientific Discovery (Basic Books: New York).Google Scholar

Porter, R. 1997. The Greatest Benefit to Mankind: A Medical History of Humanity (Norton: New York).Google Scholar

Posternak, M. A., and Zimmerman, M.. 2003. “How accurate are patients in reporting their antidepressant treatment history?,” J Affect Disord, 75: 115–24.CrossRefGoogle ScholarPubMed

Prentice, R. L., Langer, R. D., Stefanick, M. L., et al. 2006. “Combined analysis of Women’s Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease,” Am J Epidemiol, 163: 589–99.CrossRefGoogle ScholarPubMed

Roberts, L. W., Warner, T. D., Brody, J. L., et al. 2002. “Patient and psychiatrist ratings of hypothetical schizophrenia research protocols: Assessment of harm potential and factors influencing participation decisions,” Am J Psychiatry, 159: 573–84.CrossRefGoogle ScholarPubMed

Robin, E. D. 1985. “The cult of the Swan-Ganz catheter: Overuse and abuse of pulmonary flow catheters,” Ann Intern Med, 103: 445–9.CrossRefGoogle ScholarPubMed

Robins, E., and Guze, S. B.. 1970. “Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia,” Am J Psychiatry, 126: 983–7.CrossRefGoogle ScholarPubMed

Rosner, G. L., Stadler, W., and Ratain, M. J.. 2002. “Randomized discontinuation design: Application to cytostatic antineoplastic agents,” J Clin Oncol, 20: 4478–84.CrossRefGoogle ScholarPubMed

Rothman, K. J., and Greenland, S.. 1998. Modern Epidemiology (Lippincott-Raven: Philadelphia).Google Scholar

Rush, A. J., Trivedi, M. H., Wisniewski, S. R., et al. 2006. “Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report,” Am J Psychiatry, 163: 1905–17.CrossRefGoogle ScholarPubMed

Rush, A. J., Trivedi, M. H., Wisniewski, S. R., et al. 2006. “Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression,” N Engl J Med, 354: 1231–42.CrossRefGoogle ScholarPubMed

Ruskin, J. N. 1989. “The cardiac arrhythmia suppression trial (CAST),” N Engl J Med, 321: 386–8.CrossRefGoogle ScholarPubMed

Rutherford, B. R., Mori, S., Sneed, J. R., Pimontel, M. A., and Roose, S. P.. 2012. “Contribution of spontaneous improvement to placebo response in depression: A meta-analytic review,” J Psychiatr Res, 46: 697–702. https://doi.org/10.1016/j.jpsychires.2012.02.008.CrossRefGoogle ScholarPubMed

Sachs, G. S., Grossman, F., Ghaemi, S. N., Okamoto, A., and Bowden, C. L.. 2002. “Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: A double-blind, placebo-controlled comparison of efficacy and safety,” Am J Psychiatry, 159: 1146–54.CrossRefGoogle ScholarPubMed

Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., et al. 2007. “Effectiveness of adjunctive antidepressant treatment for bipolar depression,” N Engl J Med, 356: 1711–22.CrossRefGoogle ScholarPubMed

Sackett, D. L., Strauss, S., Richardson, W. S., Rosenberg, W., and Haynes, R. B.. 2000. Evidence Based Medicine (Churchill Livingstone: London).Google Scholar

Salsburg, D. 2001. The Lady Tasting Tea: How Statistics Revolutionized Science in the Twentieth Century (W H Freeman and Company: New York).Google Scholar

Schick, E. C., Jr., Liang, C. S., Heupler, F. A., Jr., et al. 1982. “Randomized withdrawal from nifedipine: Placebo-controlled study in patients with coronary artery spasm,” Am Heart J, 104: 690–7.CrossRefGoogle ScholarPubMed

Selker, H. P., Oye, K. A., Eichler, H. G., et al. 2013. “A proposal for integrated efficacy-to-effectiveness (E2E) clinical trials,” Clin Pharmacol Ther, 95: 147–53.Google ScholarPubMed

Sharma, M. R., Stadler, W. M., and Ratain, M. J.. 2011. “Randomized phase II trials: A long-term investment with promising returns,” J Natl Cancer Inst, 103: 1093–100.CrossRefGoogle ScholarPubMed

Shepherd, M. 1993. “The placebo: From specificity to the non-specific and back,” Psychol Med, 23: 569–78.CrossRefGoogle Scholar

Silberman, E. K., and Snyderman, D. A.. 1997. “Research without external funding in North American psychiatry,” Am J Psychiatry, 154: 1159–60.Google ScholarPubMed

Silverman, WA. 1998. Where’s the Evidence? Debates in Modern Medicine (Oxford University Press: New York).Google Scholar

Sleight, P. 2000. “Debate: Subgroup analyses in clinical trials: fun to look at – but don’t believe them!” Curr Control Trials Cardiovasc Med, 1: 25–7.CrossRefGoogle Scholar

Smith, G. C, S., and Pell, J. P.. 2003. “Parachute use to prevent death and major trauma related to gravitational challenge: Systematic review of randomized controlled trials,” BMJ, 327: 1459–61.CrossRefGoogle Scholar

Soldani, F., Ghaemi, S. N., and Baldessarini, R.. 2005. “Research methods in psychiatric treatment studies: Critique and proposals,” Acta Psychiatr Scand, 112: 1–3.Google ScholarPubMed

Sox, H. C., and Rennie, D.. 2006. “Research misconduct, retraction, and cleansing the medical literature: Lessons from the Poehlman case,” Ann Intern Med, 144: 609–13.CrossRefGoogle ScholarPubMed

Sprock, J. 1988. “Classification of schizoaffective disorder,” Compr. Psychiatry, 29: 55–71.CrossRefGoogle ScholarPubMed

Stahl, S. M. 2002. “Antipsychotic polypharmacy: Evidence based or eminence based?” Acta Psychiatr Scand, 106: 321–2.CrossRefGoogle ScholarPubMed

Stahl, S. M. 2005. Essential Psychopharmacology (Cambridge University Press: Cambridge UK).Google Scholar

Stigler, S. M. 1986. The History of Statistics: The Measurement of Uncertainty before 1900 (Harvard University Press: Cambridge, MA).Google Scholar

Suppes, T., Vieta, E., Liu, S., Brecher, M., and Paulsson, B.. 2009. “Maintenance treatment for patients with bipolar I disorder: Results from a North American study of quetiapine in combination with lithium or divalproex (trial 127),” Am J Psychiatry, 166: 476–88.CrossRefGoogle ScholarPubMed

Tatsioni, A., Bonitsis, N. G., and Ioannidis, J. P.. 2007. “Persistence of contradicted claims in the literature,” JAMA, 298: 2517–26.CrossRefGoogle ScholarPubMed

Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., and Rosenthal, R.. 2008. “Selective publication of antidepressant trials and its influence on apparent efficacy,” N Engl J Med, 358: 252–60.CrossRefGoogle ScholarPubMed

Vieta, E., Suppes, T., Eggens, I., et al. 2008. “Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126),” J Affect Disord, 109: 251–63.CrossRefGoogle ScholarPubMed

Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., and Drazen, J. M.. 2007. “Statistics in medicine–reporting of subgroup analyses in clinical trials,” N Engl J Med, 357: 2189–94.CrossRefGoogle ScholarPubMed

Weisler, R. H., Nolen, W. A., Neijber, A., Hellqvist, A., and Paulsson, B.. 2011. “Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar i disorder (trial 144: A randomized controlled study),” J Clin Psychiatry, 72: 1452–64. http://dx.doi.org/10.4088/JCP.11m06878.CrossRefGoogle ScholarPubMed

Yastrubetskaya, O., Chiu, E., and O’Connell, S.. 1997. “Is good clinical research practice for clinical trials good clinical practice?” Int J Geriatr Psychiatry, 12: 227–31.3.0.CO;2-#>CrossRefGoogle ScholarPubMed

Zimmerman, M., Mattia, J. I., and Posternak, M. A.. 2002. “Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?” Am J Psychiatry, 159: 469–73.CrossRefGoogle ScholarPubMed